메뉴 건너뛰기




Volumn 156, Issue 4, 2014, Pages 633-648

Structural insights on the role of antibodies in HIV-1 vaccine and therapy

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; AMINO ACID; ANTIGEN; CD4 ANTIBODY; EPITOPE; GLYCAN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; N LINKED GLYCAN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

EID: 84894173514     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2014.01.052     Document Type: Review
Times cited : (284)

References (159)
  • 2
    • 80655143478 scopus 로고    scopus 로고
    • Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation
    • S.M. Alam, H.X. Liao, S.M. Dennison, F. Jaeger, R. Parks, K. Anasti, A. Foulger, M. Donathan, J. Lucas, and L. Verkoczy et al. Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation J. Virol. 85 2011 11725 11731
    • (2011) J. Virol. , vol.85 , pp. 11725-11731
    • Alam, S.M.1    Liao, H.X.2    Dennison, S.M.3    Jaeger, F.4    Parks, R.5    Anasti, K.6    Foulger, A.7    Donathan, M.8    Lucas, J.9    Verkoczy, L.10
  • 4
    • 84855466746 scopus 로고    scopus 로고
    • Antibody-based protection against HIV infection by vectored immunoprophylaxis
    • A.B. Balazs, J. Chen, C.M. Hong, D.S. Rao, L. Yang, and D. Baltimore Antibody-based protection against HIV infection by vectored immunoprophylaxis Nature 481 2012 81 84
    • (2012) Nature , vol.481 , pp. 81-84
    • Balazs, A.B.1    Chen, J.2    Hong, C.M.3    Rao, D.S.4    Yang, L.5    Baltimore, D.6
  • 7
    • 84890196626 scopus 로고    scopus 로고
    • Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy
    • A. Bartesaghi, A. Merk, M.J. Borgnia, J.L. Milne, and S. Subramaniam Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy Nat. Struct. Mol. Biol. 20 2013 1352 1357
    • (2013) Nat. Struct. Mol. Biol. , vol.20 , pp. 1352-1357
    • Bartesaghi, A.1    Merk, A.2    Borgnia, M.J.3    Milne, J.L.4    Subramaniam, S.5
  • 8
    • 0032100706 scopus 로고    scopus 로고
    • Affinity dependence of the B cell response to antigen: A threshold, a ceiling, and the importance of off-rate
    • DOI 10.1016/S1074-7613(00)80580-4
    • F.D. Batista, and M.S. Neuberger Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate Immunity 8 1998 751 759 (Pubitemid 28294522)
    • (1998) Immunity , vol.8 , Issue.6 , pp. 751-759
    • Batista, F.D.1    Neuberger, M.S.2
  • 9
    • 56449131391 scopus 로고    scopus 로고
    • Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
    • J.M. Binley, E.A. Lybarger, E.T. Crooks, M.S. Seaman, E. Gray, K.L. Davis, J.M. Decker, D. Wycuff, L. Harris, and N. Hawkins et al. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C J. Virol. 82 2008 11651 11668
    • (2008) J. Virol. , vol.82 , pp. 11651-11668
    • Binley, J.M.1    Lybarger, E.A.2    Crooks, E.T.3    Seaman, M.S.4    Gray, E.5    Davis, K.L.6    Decker, J.M.7    Wycuff, D.8    Harris, L.9    Hawkins, N.10
  • 10
    • 80052938385 scopus 로고    scopus 로고
    • Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors
    • M. Bonsignori, K.K. Hwang, X. Chen, C.Y. Tsao, L. Morris, E. Gray, D.J. Marshall, J.A. Crump, S.H. Kapiga, and N.E. Sam et al. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors J. Virol. 85 2011 9998 10009
    • (2011) J. Virol. , vol.85 , pp. 9998-10009
    • Bonsignori, M.1    Hwang, K.K.2    Chen, X.3    Tsao, C.Y.4    Morris, L.5    Gray, E.6    Marshall, D.J.7    Crump, J.A.8    Kapiga, S.H.9    Sam, N.E.10
  • 14
    • 84880667257 scopus 로고    scopus 로고
    • Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10
    • Y. Chen, J. Zhang, K.K. Hwang, H. Bouton-Verville, S.M. Xia, A. Newman, Y.B. Ouyang, B.F. Haynes, and L. Verkoczy Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10 J. Immunol. 191 2013 1260 1275
    • (2013) J. Immunol. , vol.191 , pp. 1260-1275
    • Chen, Y.1    Zhang, J.2    Hwang, K.K.3    Bouton-Verville, H.4    Xia, S.M.5    Newman, A.6    Ouyang, Y.B.7    Haynes, B.F.8    Verkoczy, L.9
  • 15
    • 0036091692 scopus 로고    scopus 로고
    • Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
    • DOI 10.1128/JVI.76.11.5315-5325.2002
    • E. Chertova, J.W. Bess Jr., B.J. Crise, R.C. Sowder II, T.M. Schaden, J.M. Hilburn, J.A. Hoxie, R.E. Benveniste, J.D. Lifson, L.E. Henderson, and L.O. Arthur Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus J. Virol. 76 2002 5315 5325 (Pubitemid 34517882)
    • (2002) Journal of Virology , vol.76 , Issue.11 , pp. 5315-5325
    • Chertova, E.1    Bess Jr., J.W.2    Crise, B.J.3    Sowder II, R.C.4    Schaden, T.M.5    Hilburn, J.M.6    Hoxie, J.A.7    Benveniste, R.E.8    Lifson, J.D.9    Henderson, L.E.10    Arthur, L.O.11
  • 18
    • 0023176265 scopus 로고
    • Antibody response to human immunodeficiency virus after primary infection
    • D.A. Cooper, A.A. Imrie, and R. Penny Antibody response to human immunodeficiency virus after primary infection J. Infect. Dis. 155 1987 1113 1118 (Pubitemid 17080483)
    • (1987) Journal of Infectious Diseases , vol.155 , Issue.6 , pp. 1113-1118
    • Cooper, D.A.1    Imrie, A.A.2    Penny, R.3
  • 19
    • 84861217014 scopus 로고    scopus 로고
    • HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response
    • V. Cortez, K. Odem-Davis, R.S. McClelland, W. Jaoko, and J. Overbaugh HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response PLoS Pathog. 8 2012 e1002611
    • (2012) PLoS Pathog. , vol.8 , pp. 1002611
    • Cortez, V.1    Odem-Davis, K.2    McClelland, R.S.3    Jaoko, W.4    Overbaugh, J.5
  • 22
    • 0025735965 scopus 로고
    • Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
    • E.S. Daar, T. Moudgil, R.D. Meyer, and D.D. Ho Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection N. Engl. J. Med. 324 1991 961 964
    • (1991) N. Engl. J. Med. , vol.324 , pp. 961-964
    • Daar, E.S.1    Moudgil, T.2    Meyer, R.D.3    Ho, D.D.4
  • 31
    • 84872817036 scopus 로고    scopus 로고
    • Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals
    • Z. Euler, M.J. van Gils, B.D. Boeser-Nunnink, H. Schuitemaker, and D. van Manen Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals PLoS ONE 8 2013 e54684
    • (2013) PLoS ONE , vol.8 , pp. 54684
    • Euler, Z.1    Van Gils, M.J.2    Boeser-Nunnink, B.D.3    Schuitemaker, H.4    Van Manen, D.5
  • 33
    • 0025856601 scopus 로고
    • Kinetic maturation of an immune response
    • J. Foote, and C. Milstein Kinetic maturation of an immune response Nature 352 1991 530 532 (Pubitemid 21912377)
    • (1991) Nature , vol.352 , Issue.6335 , pp. 530-532
    • Foote, J.1    Milstein, C.2
  • 35
    • 0034094425 scopus 로고    scopus 로고
    • The RAG proteins and V(D)J recombination: Complexes, ends, and transposition
    • DOI 10.1146/annurev.immunol.18.1.495
    • S.D. Fugmann, A.I. Lee, P.E. Shockett, I.J. Villey, and D.G. Schatz The RAG proteins and V(D)J recombination: complexes, ends, and transposition Annu. Rev. Immunol. 18 2000 495 527 (Pubitemid 30365389)
    • (2000) Annual Review of Immunology , vol.18 , pp. 495-527
    • Fugmann, S.D.1    Lee, A.I.2    Shockett, P.E.3    Villey, I.J.4    Schatz, D.G.5
  • 36
    • 84865096278 scopus 로고    scopus 로고
    • Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: Implications for use in vaccine studies
    • R. Gautam, Y. Nishimura, W.R. Lee, O. Donau, A. Buckler-White, M. Shingai, R. Sadjadpour, S.D. Schmidt, C.C. LaBranche, and B.F. Keele et al. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies J. Virol. 86 2012 8516 8526
    • (2012) J. Virol. , vol.86 , pp. 8516-8526
    • Gautam, R.1    Nishimura, Y.2    Lee, W.R.3    Donau, O.4    Buckler-White, A.5    Shingai, M.6    Sadjadpour, R.7    Schmidt, S.D.8    Labranche, C.C.9    Keele, B.F.10
  • 38
    • 84858389346 scopus 로고    scopus 로고
    • Outwitting evolution: Fighting drug-resistant TB, malaria, and HIV
    • D.E. Goldberg, R.F. Siliciano, and W.R. Jacobs Jr. Outwitting evolution: fighting drug-resistant TB, malaria, and HIV Cell 148 2012 1271 1283
    • (2012) Cell , vol.148 , pp. 1271-1283
    • Goldberg, D.E.1    Siliciano, R.F.2    Jacobs Jr., W.R.3
  • 41
    • 77954983245 scopus 로고    scopus 로고
    • Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance
    • P.M. Grant, and A.R. Zolopa Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance Curr. Opin. Investig. Drugs 11 2010 901 910
    • (2010) Curr. Opin. Investig. Drugs , vol.11 , pp. 901-910
    • Grant, P.M.1    Zolopa, A.R.2
  • 43
    • 79955389756 scopus 로고    scopus 로고
    • The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection
    • CAPRISA002 Study Team
    • E.S. Gray, M.C. Madiga, T. Hermanus, P.L. Moore, C.K. Wibmer, N.L. Tumba, L. Werner, K. Mlisana, S. Sibeko, C. Williamson CAPRISA002 Study Team The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection J. Virol. 85 2011 4828 4840
    • (2011) J. Virol. , vol.85 , pp. 4828-4840
    • Gray, E.S.1    Madiga, M.C.2    Hermanus, T.3    Moore, P.L.4    Wibmer, C.K.5    Tumba, N.L.6    Werner, L.7    Mlisana, K.8    Sibeko, S.9    Williamson, C.10
  • 44
    • 84880683631 scopus 로고    scopus 로고
    • Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model
    • H. Gruell, S. Bournazos, J.V. Ravetch, A. Ploss, M.C. Nussenzweig, and J. Pietzsch Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model J. Virol. 87 2013 8535 8544
    • (2013) J. Virol. , vol.87 , pp. 8535-8544
    • Gruell, H.1    Bournazos, S.2    Ravetch, J.V.3    Ploss, A.4    Nussenzweig, M.C.5    Pietzsch, J.6
  • 45
    • 84865632697 scopus 로고    scopus 로고
    • Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection
    • INSIGHT SMART and SPARTAC Investigators
    • E. Hamlyn, F.M. Ewings, K. Porter, D.A. Cooper, G. Tambussi, M. Schechter, C. Pedersen, J.F. Okulicz, M. McClure, A. Babiker INSIGHT SMART and SPARTAC Investigators Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection PLoS ONE 7 2012 e43754
    • (2012) PLoS ONE , vol.7 , pp. 43754
    • Hamlyn, E.1    Ewings, F.M.2    Porter, K.3    Cooper, D.A.4    Tambussi, G.5    Schechter, M.6    Pedersen, C.7    Okulicz, J.F.8    McClure, M.9    Babiker, A.10
  • 47
    • 84860759632 scopus 로고    scopus 로고
    • B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study
    • B.F. Haynes, G. Kelsoe, S.C. Harrison, and T.B. Kepler B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study Nat. Biotechnol. 30 2012 423 433
    • (2012) Nat. Biotechnol. , vol.30 , pp. 423-433
    • Haynes, B.F.1    Kelsoe, G.2    Harrison, S.C.3    Kepler, T.B.4
  • 50
    • 0037227768 scopus 로고    scopus 로고
    • SF162P3 maps to envelope gp120
    • DOI 10.1128/JVI.77.2.989-998.2003
    • M. Hsu, J.M. Harouse, A. Gettie, C. Buckner, J. Blanchard, and C. Cheng-Mayer Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120 J. Virol. 77 2003 989 998 (Pubitemid 36055521)
    • (2003) Journal of Virology , vol.77 , Issue.2 , pp. 989-998
    • Hsu, M.1    Harouse, J.M.2    Gettie, A.3    Buckner, C.4    Blanchard, J.5    Cheng-Mayer, C.6
  • 53
    • 0032905728 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma
    • DOI 10.1038/5576
    • T. Igarashi, C. Brown, A. Azadegan, N. Haigwood, D. Dimitrov, M.A. Martin, and R. Shibata Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma Nat. Med. 5 1999 211 216 (Pubitemid 29068529)
    • (1999) Nature Medicine , vol.5 , Issue.2 , pp. 211-216
    • Igarashi, T.1    Brown, C.2    Azadegan, A.3    Haigwood, N.4    Dimitrov, D.5    Martin, M.A.6    Shibata, R.7
  • 55
    • 0022558297 scopus 로고
    • Replacing the complementary determining regions in a human antibody with those from a mouse
    • P.T. Jones, P.H. Dear, J. Foote, M.S. Neuberger, and G. Winter Replacing the complementarity-determining regions in a human antibody with those from a mouse Nature 321 1986 522 525 (Pubitemid 16052256)
    • (1986) Nature , vol.321 , Issue.6069 , pp. 522-525
    • Jones, P.T.1    Dear, P.H.2    Foote, J.3
  • 58
    • 84878519611 scopus 로고    scopus 로고
    • Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans
    • J.P. Julien, D. Sok, R. Khayat, J.H. Lee, K.J. Doores, L.M. Walker, A. Ramos, D.C. Diwanji, R. Pejchal, and A. Cupo et al. Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans PLoS Pathog. 9 2013 e1003342
    • (2013) PLoS Pathog. , vol.9 , pp. 1003342
    • Julien, J.P.1    Sok, D.2    Khayat, R.3    Lee, J.H.4    Doores, K.J.5    Walker, L.M.6    Ramos, A.7    Diwanji, D.C.8    Pejchal, R.9    Cupo, A.10
  • 59
    • 33646181086 scopus 로고    scopus 로고
    • Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus
    • D. Jung, C. Giallourakis, R. Mostoslavsky, and F.W. Alt Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus Annu. Rev. Immunol. 24 2006 541 570
    • (2006) Annu. Rev. Immunol. , vol.24 , pp. 541-570
    • Jung, D.1    Giallourakis, C.2    Mostoslavsky, R.3    Alt, F.W.4
  • 60
    • 77954042425 scopus 로고    scopus 로고
    • Few and far between: How HIV may be evading antibody avidity
    • J.S. Klein, and P.J. Bjorkman Few and far between: how HIV may be evading antibody avidity PLoS Pathog. 6 2010 e1000908
    • (2010) PLoS Pathog. , vol.6 , pp. 1000908
    • Klein, J.S.1    Bjorkman, P.J.2
  • 62
    • 84866443327 scopus 로고    scopus 로고
    • Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein
    • F. Klein, C. Gaebler, H. Mouquet, D.N. Sather, C. Lehmann, J.F. Scheid, Z. Kraft, Y. Liu, J. Pietzsch, and A. Hurley et al. Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein J. Exp. Med. 209 2012 1469 1479
    • (2012) J. Exp. Med. , vol.209 , pp. 1469-1479
    • Klein, F.1    Gaebler, C.2    Mouquet, H.3    Sather, D.N.4    Lehmann, C.5    Scheid, J.F.6    Kraft, Z.7    Liu, Y.8    Pietzsch, J.9    Hurley, A.10
  • 68
    • 0028337166 scopus 로고
    • Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
    • R.A. Koup, J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome J. Virol. 68 1994 4650 4655 (Pubitemid 24183063)
    • (1994) Journal of Virology , vol.68 , Issue.7 , pp. 4650-4655
    • Koup, R.A.1    Safrit, J.T.2    Cao, Y.3    Andrews, C.A.4    McLeod, G.5    Borkowsky, W.6    Farthing, C.7    Ho, D.D.8
  • 69
    • 38949206356 scopus 로고    scopus 로고
    • Passive immunization as tool to identify protective HIV-1 env epitopes
    • DOI 10.2174/157016207782418506
    • V.G. Kramer, N.B. Siddappa, and R.M. Ruprecht Passive immunization as tool to identify protective HIV-1 Env epitopes Curr. HIV Res. 5 2007 642 655 (Pubitemid 351210997)
    • (2007) Current HIV Research , vol.5 , Issue.6 , pp. 642-655
    • Kramer, V.G.1    Siddappa, N.B.2    Ruprecht, R.M.3
  • 70
    • 84866495323 scopus 로고    scopus 로고
    • Human antibodies that neutralize HIV-1: Identification, structures, and B cell ontogenies
    • P.D. Kwong, and J.R. Mascola Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies Immunity 37 2012 412 425
    • (2012) Immunity , vol.37 , pp. 412-425
    • Kwong, P.D.1    Mascola, J.R.2
  • 71
    • 0032543307 scopus 로고    scopus 로고
    • Structure of an HIV gp 120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
    • DOI 10.1038/31405
    • P.D. Kwong, R. Wyatt, J. Robinson, R.W. Sweet, J. Sodroski, and W.A. Hendrickson Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody Nature 393 1998 648 659 (Pubitemid 28289647)
    • (1998) Nature , vol.393 , Issue.6686 , pp. 648-659
    • Kwong, P.D.1    Wyatt, R.2    Robinson, J.3    Sweet, R.W.4    Sodroski, J.5    Hendrickson, W.A.6
  • 73
    • 84883187027 scopus 로고    scopus 로고
    • Broadly neutralizing antibodies and the search for an HIV-1 vaccine: The end of the beginning
    • P.D. Kwong, J.R. Mascola, and G.J. Nabel Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning Nat. Rev. Immunol. 13 2013 693 701
    • (2013) Nat. Rev. Immunol. , vol.13 , pp. 693-701
    • Kwong, P.D.1    Mascola, J.R.2    Nabel, G.J.3
  • 74
    • 79958033481 scopus 로고    scopus 로고
    • IMGT unique numbering for the variable (V), constant (C), and groove (G) domains of IG, TR, MH, IgSF, and MhSF
    • M.P. Lefranc IMGT unique numbering for the variable (V), constant (C), and groove (G) domains of IG, TR, MH, IgSF, and MhSF Cold Spring Harb Protoc 2011 2011 633 642
    • (2011) Cold Spring Harb Protoc , vol.2011 , pp. 633-642
    • Lefranc, M.P.1
  • 78
    • 84878566279 scopus 로고    scopus 로고
    • Inhibition of the HIV-1 spike by single-PG9/16-antibody binding suggests a coordinated-activation model for its three protomeric units
    • R. Löving, M. Sjöberg, S.R. Wu, J.M. Binley, and H. Garoff Inhibition of the HIV-1 spike by single-PG9/16-antibody binding suggests a coordinated-activation model for its three protomeric units J. Virol. 87 2013 7000 7007
    • (2013) J. Virol. , vol.87 , pp. 7000-7007
    • Löving, R.1    Sjöberg, M.2    Wu, S.R.3    Binley, J.M.4    Garoff, H.5
  • 82
    • 84874561170 scopus 로고    scopus 로고
    • Neutralizing antibodies to HIV-1 induced by immunization
    • L.E. McCoy, and R.A. Weiss Neutralizing antibodies to HIV-1 induced by immunization J. Exp. Med. 210 2013 209 223
    • (2013) J. Exp. Med. , vol.210 , pp. 209-223
    • McCoy, L.E.1    Weiss, R.A.2
  • 91
    • 84862314634 scopus 로고    scopus 로고
    • Polyreactive antibodies in adaptive immune responses to viruses
    • H. Mouquet, and M.C. Nussenzweig Polyreactive antibodies in adaptive immune responses to viruses Cell. Mol. Life Sci. 69 2012 1435 1445
    • (2012) Cell. Mol. Life Sci. , vol.69 , pp. 1435-1445
    • Mouquet, H.1    Nussenzweig, M.C.2
  • 96
    • 34247106331 scopus 로고    scopus 로고
    • An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10
    • DOI 10.1128/JVI.02588-06
    • J.D. Nelson, F.M. Brunel, R. Jensen, E.T. Crooks, R.M. Cardoso, M. Wang, A. Hessell, I.A. Wilson, J.M. Binley, and P.E. Dawson et al. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10 J. Virol. 81 2007 4033 4043 (Pubitemid 46586898)
    • (2007) Journal of Virology , vol.81 , Issue.8 , pp. 4033-4043
    • Nelson, J.D.1    Brunel, F.M.2    Jensen, R.3    Crooks, E.T.4    Cardoso, R.M.F.5    Wang, M.6    Hessell, A.7    Wilson, I.A.8    Binley, J.M.9    Dawson, P.E.10    Burton, D.R.11    Zwick, M.B.12
  • 97
    • 37549036732 scopus 로고    scopus 로고
    • Fcgamma receptors as regulators of immune responses
    • F. Nimmerjahn, and J.V. Ravetch Fcgamma receptors as regulators of immune responses Nat. Rev. Immunol. 8 2008 34 47
    • (2008) Nat. Rev. Immunol. , vol.8 , pp. 34-47
    • Nimmerjahn, F.1    Ravetch, J.V.2
  • 102
    • 84874203056 scopus 로고    scopus 로고
    • N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: Inferences from heavy-light chain complementation of function
    • M. Pancera, Y. Yang, M.K. Louder, J. Gorman, G. Lu, J.S. McLellan, J. Stuckey, J. Zhu, D.R. Burton, and W.C. Koff et al. N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function PLoS ONE 8 2013 e55701
    • (2013) PLoS ONE , vol.8 , pp. 55701
    • Pancera, M.1    Yang, Y.2    Louder, M.K.3    Gorman, J.4    Lu, G.5    McLellan, J.S.6    Stuckey, J.7    Zhu, J.8    Burton, D.R.9    Koff, W.C.10
  • 106
    • 77956048307 scopus 로고    scopus 로고
    • Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus
    • R.L. Powell, T. Kinge, and P.N. Nyambi Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus J. Virol. 84 2010 9415 9426
    • (2010) J. Virol. , vol.84 , pp. 9415-9426
    • Powell, R.L.1    Kinge, T.2    Nyambi, P.N.3
  • 108
    • 0028794835 scopus 로고
    • Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process
    • C.A. Reynaud, C. Garcia, W.R. Hein, and J.C. Weill Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process Cell 80 1995 115 125
    • (1995) Cell , vol.80 , pp. 115-125
    • Reynaud, C.A.1    Garcia, C.2    Hein, W.R.3    Weill, J.C.4
  • 110
    • 0027537122 scopus 로고
    • Hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120
    • J.T. Safrit, M.S. Fung, C.A. Andrews, D.G. Braun, W.N. Sun, T.W. Chang, and R.A. Koup hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120 AIDS 7 1993 15 21 (Pubitemid 23069026)
    • (1993) AIDS , vol.7 , Issue.1 , pp. 15-21
    • Safrit, J.T.1    Fung, M.S.C.2    Andrews, C.A.3    Braun, D.G.4    Sun, W.N.C.5    Chang, T.W.6    Koup, R.A.7
  • 111
    • 33748925430 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity
    • DOI 10.1128/JVI.00141-06
    • M. Sagar, X. Wu, S. Lee, and J. Overbaugh Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity J. Virol. 80 2006 9586 9598 (Pubitemid 44435633)
    • (2006) Journal of Virology , vol.80 , Issue.19 , pp. 9586-9598
    • Sagar, M.1    Wu, X.2    Lee, S.3    Overbaugh, J.4
  • 112
    • 84884678235 scopus 로고    scopus 로고
    • A next-generation cleaved, soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies
    • R.W. Sanders, R. Derking, A. Cupo, J.P. Julien, A. Yasmeen, N. de Val, H.J. Kim, C. Blattner, A.T. de la Peña, and J. Korzun et al. A next-generation cleaved, soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies PLoS Pathog. 9 2013 e1003618
    • (2013) PLoS Pathog. , vol.9 , pp. 1003618
    • Sanders, R.W.1    Derking, R.2    Cupo, A.3    Julien, J.P.4    Yasmeen, A.5    De Val, N.6    Kim, H.J.7    Blattner, C.8    De La Peña, A.T.9    Korzun, J.10
  • 114
    • 84869204900 scopus 로고    scopus 로고
    • Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus
    • D.N. Sather, S. Carbonetti, J. Kehayia, Z. Kraft, I. Mikell, J.F. Scheid, F. Klein, and L. Stamatatos Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus J. Virol. 86 2012 12676 12685
    • (2012) J. Virol. , vol.86 , pp. 12676-12685
    • Sather, D.N.1    Carbonetti, S.2    Kehayia, J.3    Kraft, Z.4    Mikell, I.5    Scheid, J.F.6    Klein, F.7    Stamatatos, L.8
  • 115
    • 78649339280 scopus 로고    scopus 로고
    • New templates for HIV-1 antibody-based vaccine design
    • Q.J. Sattentau, and A.J. McMichael New templates for HIV-1 antibody-based vaccine design F1000 Biol. Rep. 2 2010 60
    • (2010) F1000 Biol. Rep. , vol.2 , pp. 60
    • Sattentau, Q.J.1    McMichael, A.J.2
  • 116
    • 0028801450 scopus 로고
    • Epitope exposure on functional, oligomeric HIV-1 gp41 molecules
    • Q.J. Sattentau, S. Zolla-Pazner, and P. Poignard Epitope exposure on functional, oligomeric HIV-1 gp41 molecules Virology 206 1995 713 717
    • (1995) Virology , vol.206 , pp. 713-717
    • Sattentau, Q.J.1    Zolla-Pazner, S.2    Poignard, P.3
  • 120
    • 0025133520 scopus 로고
    • Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain
    • C.F. Scott Jr., S. Silver, A.T. Profy, S.D. Putney, A. Langlois, K. Weinhold, and J.E. Robinson Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain Proc. Natl. Acad. Sci. USA 87 1990 8597 8601
    • (1990) Proc. Natl. Acad. Sci. USA , vol.87 , pp. 8597-8601
    • Scott Jr., C.F.1    Silver, S.2    Profy, A.T.3    Putney, S.D.4    Langlois, A.5    Weinhold, K.6    Robinson, J.E.7
  • 123
    • 67650453747 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm
    • M.D. Simek, W. Rida, F.H. Priddy, P. Pung, E. Carrow, D.S. Laufer, J.K. Lehrman, M. Boaz, T. Tarragona-Fiol, and G. Miiro et al. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm J. Virol. 83 2009 7337 7348
    • (2009) J. Virol. , vol.83 , pp. 7337-7348
    • Simek, M.D.1    Rida, W.2    Priddy, F.H.3    Pung, P.4    Carrow, E.5    Laufer, D.S.6    Lehrman, J.K.7    Boaz, M.8    Tarragona-Fiol, T.9    Miiro, G.10
  • 124
    • 33746555576 scopus 로고    scopus 로고
    • HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
    • DOI 10.1016/S0140-6736(06)69157-5, PII S0140673606691575
    • V. Simon, D.D. Ho, and Q. Abdool Karim HIV/AIDS epidemiology, pathogenesis, prevention, and treatment Lancet 368 2006 489 504 (Pubitemid 44142771)
    • (2006) Lancet , vol.368 , Issue.9534 , pp. 489-504
    • Simon, V.1    Ho, D.D.2    Abdool Karim, Q.3
  • 125
    • 37849000389 scopus 로고    scopus 로고
    • HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane
    • Z.Y. Sun, K.J. Oh, M. Kim, J. Yu, V. Brusic, L. Song, Z. Qiao, J.H. Wang, G. Wagner, and E.L. Reinherz HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane Immunity 28 2008 52 63
    • (2008) Immunity , vol.28 , pp. 52-63
    • Sun, Z.Y.1    Oh, K.J.2    Kim, M.3    Yu, J.4    Brusic, V.5    Song, L.6    Qiao, Z.7    Wang, J.H.8    Wagner, G.9    Reinherz, E.L.10
  • 127
    • 0025821179 scopus 로고
    • A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity
    • S.A. Tilley, W.J. Honnen, M.E. Racho, M. Hilgartner, and A. Pinter A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity Res. Virol. 142 1991 247 259
    • (1991) Res. Virol. , vol.142 , pp. 247-259
    • Tilley, S.A.1    Honnen, W.J.2    Racho, M.E.3    Hilgartner, M.4    Pinter, A.5
  • 128
    • 57349127300 scopus 로고    scopus 로고
    • Initial B-cell responses to transmitted human immunodeficiency virus type 1: Virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia
    • G.D. Tomaras, N.L. Yates, P. Liu, L. Qin, G.G. Fouda, L.L. Chavez, A.C. Decamp, R.J. Parks, V.C. Ashley, and J.T. Lucas et al. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia J. Virol. 82 2008 12449 12463
    • (2008) J. Virol. , vol.82 , pp. 12449-12463
    • Tomaras, G.D.1    Yates, N.L.2    Liu, P.3    Qin, L.4    Fouda, G.G.5    Chavez, L.L.6    Decamp, A.C.7    Parks, R.J.8    Ashley, V.C.9    Lucas, J.T.10
  • 131
    • 79960405099 scopus 로고    scopus 로고
    • Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies
    • M.J. van Gils, E.M. Bunnik, B.D. Boeser-Nunnink, J.A. Burger, M. Terlouw-Klein, N. Verwer, and H. Schuitemaker Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies J. Virol. 85 2011 6986 6995
    • (2011) J. Virol. , vol.85 , pp. 6986-6995
    • Van Gils, M.J.1    Bunnik, E.M.2    Boeser-Nunnink, B.D.3    Burger, J.A.4    Terlouw-Klein, M.5    Verwer, N.6    Schuitemaker, H.7
  • 132
    • 64849095775 scopus 로고    scopus 로고
    • Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection
    • P.I. Vergidis, M.E. Falagas, and D.H. Hamer Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection Infect. Dis. Clin. North Am. 23 2009 295 308
    • (2009) Infect. Dis. Clin. North Am. , vol.23 , pp. 295-308
    • Vergidis, P.I.1    Falagas, M.E.2    Hamer, D.H.3
  • 134
    • 84883348588 scopus 로고    scopus 로고
    • Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: Selection against membrane proximal external region-associated autoreactivity limits T-dependent responses
    • L. Verkoczy, Y. Chen, J. Zhang, H. Bouton-Verville, A. Newman, B. Lockwood, R.M. Scearce, D.C. Montefiori, S.M. Dennison, and S.M. Xia et al. Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses J. Immunol. 191 2013 2538 2550
    • (2013) J. Immunol. , vol.191 , pp. 2538-2550
    • Verkoczy, L.1    Chen, Y.2    Zhang, J.3    Bouton-Verville, H.4    Newman, A.5    Lockwood, B.6    Scearce, R.M.7    Montefiori, D.C.8    Dennison, S.M.9    Xia, S.M.10
  • 138
  • 141
    • 0041689676 scopus 로고    scopus 로고
    • Predominant autoantibody production by early human B cell precursors
    • DOI 10.1126/science.1086907
    • H. Wardemann, S. Yurasov, A. Schaefer, J.W. Young, E. Meffre, and M.C. Nussenzweig Predominant autoantibody production by early human B cell precursors Science 301 2003 1374 1377 (Pubitemid 37075812)
    • (2003) Science , vol.301 , Issue.5638 , pp. 1374-1377
    • Wardemann, H.1    Yurasov, S.2    Schaefer, A.3    Young, J.W.4    Meffre, E.5    Nussenzweig, M.C.6
  • 145
    • 84864363185 scopus 로고    scopus 로고
    • Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
    • A.P. West Jr., R. Diskin, M.C. Nussenzweig, and P.J. Bjorkman Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120 Proc. Natl. Acad. Sci. USA 109 2012 E2083 E2090
    • (2012) Proc. Natl. Acad. Sci. USA , vol.109
    • West Jr., A.P.1    Diskin, R.2    Nussenzweig, M.C.3    Bjorkman, P.J.4
  • 146
    • 84879538530 scopus 로고    scopus 로고
    • Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues
    • A.P. West Jr., L. Scharf, J. Horwitz, F. Klein, M.C. Nussenzweig, and P.J. Bjorkman Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues Proc. Natl. Acad. Sci. USA 110 2013 10598 10603
    • (2013) Proc. Natl. Acad. Sci. USA , vol.110 , pp. 10598-10603
    • West Jr., A.P.1    Scharf, L.2    Horwitz, J.3    Klein, F.4    Nussenzweig, M.C.5    Bjorkman, P.J.6
  • 147
    • 84887270287 scopus 로고    scopus 로고
    • Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes
    • C.K. Wibmer, J.N. Bhiman, E.S. Gray, N. Tumba, S.S. Abdool Karim, C. Williamson, L. Morris, and P.L. Moore Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes PLoS Pathog. 9 2013 e1003738
    • (2013) PLoS Pathog. , vol.9 , pp. 1003738
    • Wibmer, C.K.1    Bhiman, J.N.2    Gray, E.S.3    Tumba, N.4    Abdool Karim, S.S.5    Williamson, C.6    Morris, L.7    Moore, P.L.8
  • 149
    • 80052942203 scopus 로고    scopus 로고
    • Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing
    • NISC Comparative Sequencing Program
    • X. Wu, T. Zhou, J. Zhu, B. Zhang, I. Georgiev, C. Wang, X. Chen, N.S. Longo, M. Louder, K. McKee NISC Comparative Sequencing Program Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing Science 333 2011 1593 1602
    • (2011) Science , vol.333 , pp. 1593-1602
    • Wu, X.1    Zhou, T.2    Zhu, J.3    Zhang, B.4    Georgiev, I.5    Wang, C.6    Chen, X.7    Longo, N.S.8    Louder, M.9    McKee, K.10
  • 150
    • 84890222476 scopus 로고    scopus 로고
    • Structural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12
    • Y. Wu, A.P. West Jr., H.J. Kim, M.E. Thornton, A.B. Ward, and P.J. Bjorkman Structural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12 Cell Rep 5 2013 1443 1455
    • (2013) Cell Rep , vol.5 , pp. 1443-1455
    • Wu, Y.1    West Jr., A.P.2    Kim, H.J.3    Thornton, M.E.4    Ward, A.B.5    Bjorkman, P.J.6
  • 151
    • 70449701456 scopus 로고    scopus 로고
    • Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
    • X. Xiao, W. Chen, Y. Feng, Z. Zhu, P. Prabakaran, Y. Wang, M.Y. Zhang, N.S. Longo, and D.S. Dimitrov Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens Biochem. Biophys. Res. Commun. 390 2009 404 409
    • (2009) Biochem. Biophys. Res. Commun. , vol.390 , pp. 404-409
    • Xiao, X.1    Chen, W.2    Feng, Y.3    Zhu, Z.4    Prabakaran, P.5    Wang, Y.6    Zhang, M.Y.7    Longo, N.S.8    Dimitrov, D.S.9
  • 154
    • 84882589754 scopus 로고    scopus 로고
    • Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies
    • NISC Comparative Sequencing Program
    • T. Zhou, J. Zhu, X. Wu, S. Moquin, B. Zhang, P. Acharya, I.S. Georgiev, H.R. Altae-Tran, G.Y. Chuang, M.G. Joyce NISC Comparative Sequencing Program Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies Immunity 39 2013 245 258
    • (2013) Immunity , vol.39 , pp. 245-258
    • Zhou, T.1    Zhu, J.2    Wu, X.3    Moquin, S.4    Zhang, B.5    Acharya, P.6    Georgiev, I.S.7    Altae-Tran, H.R.8    Chuang, G.Y.9    Joyce, M.G.10
  • 156
    • 80055115557 scopus 로고    scopus 로고
    • Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies
    • Z. Zhu, H.R. Qin, W. Chen, Q. Zhao, X. Shen, R. Schutte, Y. Wang, G. Ofek, E. Streaker, and P. Prabakaran et al. Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies J. Virol. 85 2011 11401 11408
    • (2011) J. Virol. , vol.85 , pp. 11401-11408
    • Zhu, Z.1    Qin, H.R.2    Chen, W.3    Zhao, Q.4    Shen, X.5    Schutte, R.6    Wang, Y.7    Ofek, G.8    Streaker, E.9    Prabakaran, P.10
  • 157
    • 1542615646 scopus 로고    scopus 로고
    • Identifying epitopes of HIV-1 that induce protective antibodies
    • S. Zolla-Pazner Identifying epitopes of HIV-1 that induce protective antibodies Nat. Rev. Immunol. 4 2004 199 210 (Pubitemid 38339086)
    • (2004) Nature Reviews Immunology , vol.4 , Issue.3 , pp. 199-210
    • Zolla-Pazner, S.1
  • 159
    • 11144227042 scopus 로고    scopus 로고
    • Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1
    • DOI 10.1128/JVI.79.2.1252-1261.2005
    • M.B. Zwick, R. Jensen, S. Church, M. Wang, G. Stiegler, R. Kunert, H. Katinger, and D.R. Burton Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1 J. Virol. 79 2005 1252 1261 (Pubitemid 40053907)
    • (2005) Journal of Virology , vol.79 , Issue.2 , pp. 1252-1261
    • Zwick, M.B.1    Jensen, R.2    Church, S.3    Wang, M.4    Stiegler, G.5    Kunert, R.6    Katinger, H.7    Burton, D.R.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.